作为一种潜在的瘤抑制剂,CRISP3通过调节PI3K/AKT通路来抑制高度血清性卵巢癌的进展
Mingjun Ma1,2, Xiu Tian1,2, Weiwei Cao1,2
1Department of Gynecology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai 200092, China.
Biomedicines
|February 27, 2026
概括
富含氨酸的分泌蛋白3 (CRISP3) 通过抑制PI3K/AKT通路来抑制高度血清卵巢癌 (HGSOC) 的进展. 减少CRISP3表达与晚期疾病和改变的免疫细胞透相关,表明其作为生物标志物的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 高度血清性卵巢癌 (HGSOC) 是妇科癌死亡率的主要原因.
- 富含氨酸的分泌蛋白3 (CRISP3) 在HGSOC病变发生过程中的作用尚不清楚.
研究的目的:
- 研究CRISP3在HGSOC中的临床意义和功能作用.
- 阐明底层的分子机制和作为HGSOC.生物标记物的潜力.
主要方法:
- 在OC中使用TCGA和GEO数据库对CRISP3表达的分析.
- 在体外和体内研究评估CRISP3对HGSOC细胞行为和进展的影响.
- RNA-seq,GSEA,和西部抹迹,以确定调节途径.
- 与免疫治疗反应和免疫细胞透的相关性分析.
主要成果:
- 在HGSOC中,CRISP3的表达显著降低,并在疾病进展过程中下调.
- 抑制CRISP3可以增强HGSOC细胞的增殖,迁移和入侵;过度表达可以抑制这些.
- 通过PI3K/AKT通路,CRISP3抑制了HGSOC的进展和转移.
- CRISP3表达与CD8+ T细胞,巨细胞,中性粒细胞和Th1细胞的透相关.
结论:
- 通过调节PI3K/AKT通路,CRISP3在HGSOC中起到瘤抑制作用.
- 改变CRISP3表达与HGSOC进展和免疫微环境有关.
- CRISP3有可能成为HGSOC的预后生物标志物.
相关概念视频
01:22PI3K/mTOR/AKT Signaling Pathway
5.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.9K
02:34Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
03:03mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
02:07Tumor Progression
7.6K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.6K
01:20The JAK-STAT Signaling Pathway
13.4K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.4K
01:19Interactions Between Signaling Pathways
7.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K